Emergent biosolutions signs development and manufacturing agreement with vaxart for their experimental oral vaccine candidate for coronavirus disease

Gaithersburg, md., march 18, 2020 (globe newswire) -- emergent biosolutions inc. (nyse:ebs) announced today that it has entered into an agreement with...

CDMO Ratings Summary

CDMO Quant Ranking